NCT06472037View on ClinicalTrials.gov

AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

July 1, 2025

Conditions
Locally Advanced Pancreatic Ductal Adenocarcinoma
Interventions
DRUG

Cadonilimab

10mg/kg，IV，D1，Q3W

DRUG

Gemcitabine

1000mg/m2，IV，D1、D8、D15，Q4W

DRUG

Nab-Paclitaxel

125mg/m2，IV，D1、D8、D15，Q4W

Trial Locations (1)

300052

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER